Nature Medicine, Published online: 19 August 2026; doi:10.1038/s41591-026-04586-1
Dronabinol, the pharmaceutical form of Δ9-tetrahydrocannabinol, shows promise in the treatment of nightmares related to post-traumatic stress disorder (PTSD), but additional studies are needed to confirm safety and efficacy.
